New Apria program helps reduce readmissions

 - 
Friday, August 11, 2017

LAKE FOREST, Calif. – Apria Healthcare has launched a new program for patients on non-invasive ventilation that it says significantly reduces hospital admissions.

As part of the Apria Clinical Evidence (ACE) program, respiratory therapists perform regularly scheduled home visits to help patients maintain compliance with therapy and intervene as needed to get patients back on track. During the visits, RTs monitor each patient’s progress and record their responses to a number of quality of life indicators, as well as document emergency department visits and unplanned hospital admissions.

“Apria is uniquely positioned to help these patients reduce hospital admissions by providing them with the tools and support they need for success,” said Dan Starck, CEO of Apria Healthcare. “Through the ACE program, we have seen tremendous success in reducing hospital admissions when comparing the six months prior to initiating therapy with the six months post therapy, particularly for patients diagnosed with COPD.”

Initial results from the ACE program are comparable to a recent study published in the Journal of Clinical Sleep Medicine, which demonstrated that multifaceted COPD intervention—including non-invasive ventilation, RT-led respiratory care and patient education—resulted in an 88% reduction in hospital admissions, according to Apria.

Apria is offering the ACE program nationwide through its locations in Springfield and Wilmington, Mass.